Literature DB >> 8602825

Inhibitory effects of negatively charged liposomes on nitric oxide production from macrophages stimulated by LPS.

Y Aramaki1, F Nitta, R Matsuno, Y Morimura, S Tsuchiya.   

Abstract

The effects of liposomes on nitric oxide (NO) productions induced by lipopolysaccharide were investigated using thioglycollate-induced mouse peritoneal macrophages. Negatively charged liposomes composed of phosphatidic acid (PA-liposomes) and phosphatidylserine (PS-liposomes) showed inhibitory effect on NO production in a dose dependent manner, but not in liposomes composed of phosphatidylcholine (PC-liposomes). Pretreatment of macrophages with liposomes was required in order to observe the inhibitory effect on NO production. NO production induced by IFN-gamma was also inhibited by negatively charged liposomes. To clarify the mechanism of inhibitory effect of liposomes, immune blotting was performed using anti mouse inducible nitric oxide synthase (iNOS) antibody. An immunoreactive band at 130 kDa was observed in the extract of control and PC-liposome- treated macrophages, whereas a faint or no band was observed in PS- and PA-liposome-treated ones. These finding revealed that the inhibition of NO production by negatively charged liposomes could be a result in the inhibition of iNOS induction, but not enzyme activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8602825     DOI: 10.1006/bbrc.1996.0346

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Reduction of no synthase expression and tumor necrosis factor alpha production in macrophages by amphotericin B lipid carriers.

Authors:  M Larabi; P Legrand; M Appel; S Gil; M Lepoivre; J Devissaguet; F Puisieux; G Barratt
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Liposomal induction of a heat-stable macrophage priming factor to induce nitric oxide in response to LPS.

Authors:  Y Aramaki; H Arima; T Hara; S Tsuchiya
Journal:  Pharm Res       Date:  1996-09       Impact factor: 4.200

3.  Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease.

Authors:  C M Hogaboam; B A Vallance; A Kumar; C L Addison; F L Graham; J Gauldie; S M Collins
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

4.  Synergic modulation of the inflammatory state of macrophages utilizing anti-oxidant and phosphatidylserine-containing polymer-lipid hybrid nanoparticles.

Authors:  Md Zahangir Hosain; Kazuki Yuzuriha; Masafumi Takeo; Akihiro Kishimura; Yoshihiko Murakami; Takeshi Mori; Yoshiki Katayama
Journal:  Medchemcomm       Date:  2017-06-02       Impact factor: 3.597

5.  Myelin alters the inflammatory phenotype of macrophages by activating PPARs.

Authors:  Jeroen F J Bogie; Winde Jorissen; Jo Mailleux; Philip G Nijland; Noam Zelcer; Tim Vanmierlo; Jack Van Horssen; Piet Stinissen; Niels Hellings; Jerome J A Hendriks
Journal:  Acta Neuropathol Commun       Date:  2013-08-02       Impact factor: 7.801

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.